NCT02860039 2024-10-22
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
Clinical Trials
7 trialsNCT03061955 2024-10-04
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
Wake Forest University Health Sciences
Completed
NCT01695733 2018-08-31
Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy
Washington University School of Medicine
Phase 1 Terminated
NCT01205581 2016-09-23
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
St. Jude Children's Research Hospital
Phase 2 Completed
NCT01666782 2016-06-24
IMMUNE
Rochester General Hospital
Phase 2 Completed
NCT01698177 2013-04-19
Optimizing Influenza Vaccination in Surgical Oncology Patients
Stony Brook University
Phase 4 Unknown
NCT01031719 2012-09-13
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Chiltern Pesquisa Clinica Ltda
Phase 3 Completed